We are live on
!
Find out more
RJFSA
Raymond James Financial Services Advisors Portfolio holdings
AUM
$75.1B
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+20.17%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$31.5B
AUM Growth
+$8.55B
(+37%)
Cap. Flow
+$4.25B
Cap. Flow
% of AUM
13.49%
Top 10 Holdings %
Top 10 Hldgs %
18.78%
Holding
2,958
New
539
Increased
1,172
Reduced
1,031
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$221M |
| 2 |
Cisco
CSCO
|
+$197M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$173M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$137M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$79.4M |
| 2 |
First Trust Value Line Dividend Fund
FVD
|
+$29.8M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$24.3M |
| 4 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$21.7M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.34% |
| 2 | Healthcare | 6.55% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.66% |
| 5 | Industrials | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Revvity
RVTY
$13.1B
| $907K | ﹤0.01% |
9,244
+1,586
| +21% | +$145K |
|
|
TIF
1552
DELISTED
Tiffany & Co.
TIF
| $907K | ﹤0.01% |
7,436
+3,997
| +116% | +$501K |
|
|
VG
1553
DELISTED
Vonage Holdings Corporation
VG
| $906K | ﹤0.01% |
90,061
-3,715
| -4% | -$33.3K |
|
1554
John Hancock Multifactor Small Cap ETF
JHSC
$746M
| $905K | ﹤0.01% |
38,451
-25,015
| -39% | -$549K |
|
1555
WPP
WPP
$5.82B
| $905K | ﹤0.01% |
23,140
+3,344
| +17% | +$124K |
|
1556
Donaldson
DCI
$11.1B
| $902K | ﹤0.01% |
+19,386
| New | +$857K |
|
1557
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
| $902K | ﹤0.01% |
38,003
+1,688
| +5% | +$38.1K |
|
1558
Takeda Pharmaceutical
TAK
$55.6B
| $900K | ﹤0.01% |
50,176
+23,093
| +85% | +$415K |
|
|
JNPR
1559
DELISTED
Juniper Networks
JNPR
| $898K | ﹤0.01% |
39,290
+14,847
| +61% | +$342K |
|
1560
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $896K | ﹤0.01% |
88,103
+18,248
| +26% | +$176K |
|
|
DMO
1561
Western Asset Mortgage Opportunity Fund
DMO
$120M
| $895K | ﹤0.01% |
60,988
+6,035
| +11% | +$79.7K |
|
1562
Sonoco
SON
$5.77B
| $895K | ﹤0.01% |
17,122
-46
| -0.3% | -$2.28K |
|
1563
IPG Photonics
IPGP
$3.71B
| $893K | ﹤0.01% |
5,570
+274
| +5% | +$39K |
|
1564
FNB Corp
FNB
$6.86B
| $889K | ﹤0.01% |
+118,533
| New | +$892K |
|
1565
Viking Therapeutics
VKTX
$3.84B
| $888K | ﹤0.01% |
123,138
+39,136
| +47% | +$260K |
|
1566
Northern Trust
NTRS
$35B
| $887K | ﹤0.01% |
11,182
-7,224
| -39% | -$573K |
|
1567
Radian Group
RDN
$4.87B
| $886K | ﹤0.01% |
57,097
-1,203
| -2% | -$17.8K |
|
1568
Globant
GLOB
$1.77B
| $884K | ﹤0.01% |
+5,897
| New | +$728K |
|
1569
Invesco Large Cap Growth ETF
PWB
$2.45B
| $884K | ﹤0.01% |
16,137
-94,067
| -85% | -$4.73M |
|
1570
ALPS Medical Breakthroughs ETF
SBIO
$214M
| $884K | ﹤0.01% |
21,132
-144
| -0.7% | -$5.68K |
|
1571
Delek US
DK
$4.12B
| $883K | ﹤0.01% |
50,727
+35,131
| +225% | +$671K |
|
1572
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$110M
| $877K | ﹤0.01% |
39,441
+22
| +0.1% | +$462 |
|
|
GTHX
1573
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $876K | ﹤0.01% |
+36,122
| New | +$597K |
|
1574
Nuveen Mortgage and Income Fund
JLS
$95M
| $875K | ﹤0.01% |
+44,773
| New | +$813K |
|
|
NIE
1575
Virtus Equity & Convertible Income Fund
NIE
$738M
| $868K | ﹤0.01% |
38,595
+9,007
| +30% | +$189K |
|
Similar funds
PI
ECU
EAM
AA
SA
WPL
ECU
RJT
Raymond James Financial Services Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Raymond James Financial Services Advisors held 2,958 positions worth $31.5B, up 37% from $22.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Raymond James Financial Services Advisors deployed $4.25B of net new capital in Q2 2020, opening 539 new positions and adding to 1,172 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 3,507,464 shares worth $240M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $79.4M trimmed.
- Raymond James Financial Services Advisors's largest Q2 2020 buy was iShares Core S&P Small-Cap ETF: 3,507,464 shares worth $240M.
- Raymond James Financial Services Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $127M increase.
- Raymond James Financial Services Advisors's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.4M.
- Raymond James Financial Services Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $15.5M.
- Raymond James Financial Services Advisors's ten largest holdings make up 19% of its $31.5B portfolio in Q2 2020.
- Raymond James Financial Services Advisors opened 539 new positions and closed 140 in Q2 2020.
- Raymond James Financial Services Advisors's portfolio value rose 37% quarter-over-quarter to $31.5B.
Based on Raymond James Financial Services Advisors's 13F filing for Q2 2020, filed 17 Jul 2020.